$PVCT is undervalued and I think could go much higher with announcement of new CEO. The shake up helped with dropping the price so any positive new shoots this up. The RO is far more shareholder friendly than some people out there are giving it credit. But would yes .25 is the right direction.
(2)
(0)
Provectus Biopharmaceuticals Inc. (PVCT) Stock Research Links